Clinical Trials Browser

Withdrawn × NIH × Melphalan × Clear all

NCT01251172 2017-09-28

RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma

NCT00085345 2013-07-10

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell